Increased arachidonic acid incorporation into platelet phospholipids in type 2 (non-insulin-dependent) diabetes.

R Takahashi, I Morita, Y Saito, H Ito, S Murota
Author Information

Abstract

Arachidonic acid uptake activity was measured in platelets obtained from 27 Type 2 diabetic patients and 18 age-matched control subjects. In both groups after 1 h incubation almost all the incorporated 14C-Arachidonic acid was located in the phospholipids of the platelets. Arachidonic acid was predominantly incorporated into phosphatidylcholine. The radioactivity incorporated into platelets increased linearly with incubation time, up to 90 min. The linear increase was observed at Arachidonic acid concentrations of 0.1-1.0 micrograms/ml in both groups. The rate of incorporation of radioactivity in diabetic platelets was about 1.4 times higher than that in control platelets at all Arachidonic acid concentrations studied. The Arachidonic acid uptake activity of diabetic platelets (577 +/- 26 ng/60 min per 10(9) platelets) was significantly higher than that in control platelets (410 +/- 26 ng/60 min per 10(9) platelets). No significant correlations were found between the Arachidonic acid uptake activity and fasting plasma glucose, total cholesterol or triglyceride levels. The Arachidonic acid uptake activity of platelets was significantly higher in diabetic patients with proliferative retinopathy than in those with little or no background retinopathy. In addition, there were no significant differences between control and diabetic subjects in the uptake activity of platelets for linoleic acid and oleic acid. These data may explain the elevated Arachidonic acid content in diabetic platelet phospholipids and enhancement of thromboxane synthesis in diabetes.

References

  1. Anal Biochem. 1979 Oct 1;98(2):341-5 [PMID: 115333]
  2. Pharmacol Rev. 1978 Sep;30(3):293-331 [PMID: 116251]
  3. Lipids. 1983 Jan;18(1):42-9 [PMID: 6300604]
  4. J Biol Chem. 1982 Apr 10;257(7):3510-5 [PMID: 7061494]
  5. Eur J Clin Invest. 1979 Jun;9(3):223-8 [PMID: 113223]
  6. Clin Chem. 1978 Jan;24(1):27-31 [PMID: 618662]
  7. Diabetologia. 1981 Dec;21(6):540-3 [PMID: 7338292]
  8. Br Med J (Clin Res Ed). 1983 Jan 15;286(6360):173-5 [PMID: 6401517]
  9. Thromb Res. 1980 Jul 1-15;19(1-2):211-23 [PMID: 7444853]
  10. J Lipid Res. 1973 May;14(3):296-305 [PMID: 9704073]
  11. Proc Natl Acad Sci U S A. 1975 Aug;72(8):2994-8 [PMID: 1059088]
  12. Can J Biochem Physiol. 1959 Aug;37(8):911-7 [PMID: 13671378]
  13. Prostaglandins Leukot Med. 1983 May;11(1):33-41 [PMID: 6308684]
  14. Biochim Biophys Acta. 1976 Feb 23;424(2):303-14 [PMID: 1252495]
  15. J Lab Clin Med. 1981 Jan;97(1):87-96 [PMID: 7452084]
  16. Prostaglandins Med. 1981 Jun;6(6):661-7 [PMID: 6894982]
  17. Am J Hematol. 1976;1(1):59-70 [PMID: 984037]
  18. J Clin Invest. 1977 Jul;60(1):1-6 [PMID: 874074]
  19. Thromb Res. 1980 Sep 15;19(6):823-30 [PMID: 7466751]
  20. Clin Chem. 1974 Apr;20(4):470-5 [PMID: 4818200]

MeSH Term

Aged
Arachidonic Acid
Arachidonic Acids
Blood Platelets
Diabetes Mellitus, Type 2
Diabetic Retinopathy
Fatty Acids, Nonesterified
Female
Humans
Male
Middle Aged
Phospholipids
Platelet Aggregation
Thromboxane A2

Chemicals

Arachidonic Acids
Fatty Acids, Nonesterified
Phospholipids
Arachidonic Acid
Thromboxane A2

Word Cloud

Created with Highcharts 10.0.0acidplateletsarachidonicdiabeticuptakeactivitycontrolincorporatedphospholipidsminhigherArachidonic2patientssubjectsgroups1incubationradioactivityconcentrations0incorporation+/-26ng/60per109significantlysignificantretinopathyplateletdiabetesmeasuredobtained27Type18age-matchedhalmost14C-arachidoniclocatedpredominantlyphosphatidylcholineincreasedlinearlytime90linearincreaseobserved1-1micrograms/mlrate4timesstudied577410correlationsfoundfastingplasmaglucosetotalcholesteroltriglyceridelevelsproliferativelittlebackgroundadditiondifferenceslinoleicoleicdatamayexplainelevatedcontentenhancementthromboxanesynthesisIncreasedtypenon-insulin-dependent

Similar Articles

Cited By (6)